tetano
Editor, Senior Moderator
Respir Med Case Rep
. 2020 Jun 27;31:101115.
doi: 10.1016/j.rmcr.2020.101115. eCollection 2020.
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
Pietro Sodani[SUP] 1 2 [/SUP], Luciano Mucci[SUP] 1 [/SUP], Rita Girolimetti[SUP] 1 [/SUP], Silvia Tedesco[SUP] 1 [/SUP], Francesca Monaco[SUP] 1 [/SUP], Daniele Campanozzi[SUP] 1 [/SUP], Marino Brunori[SUP] 1 [/SUP], Stefania Maltoni[SUP] 1 [/SUP], Samuele Bedetta[SUP] 1 [/SUP], Anna M Di Carlo[SUP] 1 [/SUP], Piero Candoli[SUP] 3 [/SUP], Mauro Mancini[SUP] 4 [/SUP], Alberto Rebonato[SUP] 5 [/SUP], Francesca D'Adamo[SUP] 6 [/SUP], Maria Capalbo[SUP] 7 [/SUP], Gabriele Frausini[SUP] 1 [/SUP]
Affiliations
Abstract
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 pneumonia patient case with high mortality risk factors. Our experience underlines the importance of the use of a multidisciplinary therapeutic approach in order to achieve a favorable clinical outcome. Further, enhancing the capability of the COVID-19 diagnosis with the use of the chest imaging modalities is discussed.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; Viral pneumonia.
. 2020 Jun 27;31:101115.
doi: 10.1016/j.rmcr.2020.101115. eCollection 2020.
Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
Pietro Sodani[SUP] 1 2 [/SUP], Luciano Mucci[SUP] 1 [/SUP], Rita Girolimetti[SUP] 1 [/SUP], Silvia Tedesco[SUP] 1 [/SUP], Francesca Monaco[SUP] 1 [/SUP], Daniele Campanozzi[SUP] 1 [/SUP], Marino Brunori[SUP] 1 [/SUP], Stefania Maltoni[SUP] 1 [/SUP], Samuele Bedetta[SUP] 1 [/SUP], Anna M Di Carlo[SUP] 1 [/SUP], Piero Candoli[SUP] 3 [/SUP], Mauro Mancini[SUP] 4 [/SUP], Alberto Rebonato[SUP] 5 [/SUP], Francesca D'Adamo[SUP] 6 [/SUP], Maria Capalbo[SUP] 7 [/SUP], Gabriele Frausini[SUP] 1 [/SUP]
Affiliations
- PMID: 32670785
- PMCID: PMC7320265
- DOI: 10.1016/j.rmcr.2020.101115
Abstract
The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic, threatening global public health. In the current paper, we describe our successful treatment of one COVID-19 pneumonia patient case with high mortality risk factors. Our experience underlines the importance of the use of a multidisciplinary therapeutic approach in order to achieve a favorable clinical outcome. Further, enhancing the capability of the COVID-19 diagnosis with the use of the chest imaging modalities is discussed.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; Viral pneumonia.